Weight changes and metformin use in Thai patients with IGT

Not Applicable

Recruiting

• Conditions: weight changes; weight; impaired glucose tolerance; metformin

• Registration Number: TCTR20201201004
• Lead Sponsor: Theptarin Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-12-01
• Study Completion: 2020-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

1.Patients who have newly diagnosed with impair glucose tolerance test
2.Age more than 15 years old

Exclusion Criteria

1.Previously diagnosed with diabetes
2.Pregnancy
3.Previously diagnosed with endocrine disorder; Cushing's disease, acromegaly, adrenal insufficiency
4.Taking steroids
5.Incomplete data

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body weight at 3, 6 months before and 3,6,12,24 months after the diagnosis ofIGT Body weight scale

Secondary Outcome Measures

Name	Time	Method
metformin use during the study dosage in milligram